Precycle Estradiol in Synchronization and Scheduling of Antagonist Cycles.

about

Precycle Estradiol in Synchronization and Scheduling of Antagonist Cycles.

Item

http://www.wikidata.org/entity/Q41823025

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Precycle Estradiol in Synchronization and Scheduling of Antagonist Cycles.

@en

type

Item

label

Precycle Estradiol in Synchronization and Scheduling of Antagonist Cycles.

@en

prefLabel

Precycle Estradiol in Synchronization and Scheduling of Antagonist Cycles.

@en

P1476

Precycle Estradiol in Synchronization and Scheduling of Antagonist Cycles.

@en

P2093

Mukesh Agrawal

http://www.w3.org/2001/XMLSchema#string

Shilpa Saple

http://www.w3.org/2001/XMLSchema#string

Simi Kawar

http://www.w3.org/2001/XMLSchema#string

P2860

Gonadotrophin-releasing hormone antagonists for assisted reproductive technology

Effect of estrogen priming through luteal phase and stimulation phase in poor responders in in-vitro fertilization

Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis.

Oral contraceptive pill pretreatment in ovarian stimulation with GnRH antagonists for IVF: a systematic review and meta-analysis.

IVF/ICSI outcomes between cycles with luteal estradiol (E2) pre-treatment before GnRH antagonist protocol and standard long GnRH agonist protocol: a prospective and randomized study.

Cycle scheduling for in vitro fertilization with oral contraceptive pills versus oral estradiol valerate: a randomized, controlled trial.

A luteal estradiol protocol for expected poor-responders improves embryo number and quality.

Gonadotropin-releasing hormone antagonist protocol: a novel method of ovarian stimulation in poor responders.

Controlled preparation of the endometrium with exogenous oestradiol and progesterone: a novel regimen not using a gonadotrophin-releasing hormone agonist.

Pretreatment with estrogen does not affect IVF-ICSI cycle outcome compared with no pretreatment in GnRH antagonist protocol: a prospective randomized trial.

P2888

s13224-016-0877-z

P304

295-299

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1007/S13224-016-0877-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27382226

http://www.w3.org/2001/XMLSchema#string

P932

4912497

http://www.w3.org/2001/XMLSchema#string